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Abstract

In vitro, it is difficult to infect resting CD4+ T cells with human immunodeficiency virus type 1 (HIV), but
infections readily occur in vivo. Endothelial cells (ECs) interact with resting CD4+ T cells in vivo, and we found
previously that EC stimulation leads to productive and latent HIV infection of resting CD4+ T cells. In this study,
we further characterize the interactions between EC and resting T cells. We found that resting CD4+ T cells did
not require direct contact with EC for productive and/or latent infection to occur, indicating the involvement of
soluble factors. Among 30 cytokines tested in a multiplex enzyme-linked immunosorbent assay (ELISA), we
found that expressions for IL-6, IL-8, and CCL2 were much higher in EC-stimulated resting T cells than resting T
cells cultured alone. IL-6 was found to be the soluble factor responsible for inducing productive infection of
resting T cells, although direct contact with EC had an added effect. However, none of the cytokines tested, IL-6,
IL-8, or CCL2, induced additional latent infection in resting T cells, suggesting that unidentified cytokines were
involved. Intracellular molecules MURR1, c-Jun N-terminal kinase ( JNK), and glucose transporter-1 (GLUT1)
were previously shown in blocking HIV infection of resting CD4+ T cells. We found that the concentrations of
these proteins were not significantly different in resting T cells before and after stimulation by EC; therefore, they
are not likely involved in EC stimulation of resting CD4+ T cells, and a new mechanism is yet to be identified.
Keywords: HIV, HIV/AIDS pathogenesis, T cells, viral reservoirs
Introduction

A

major barrier to eradicating HIV is the latent reservoir
for HIV-1 in resting CD4+ T cells. This reservoir ensures
viral persistence in infected patients, and its elimination
could greatly advance HIV cure research.
Since the discovery of the reservoir in the 1990s, much has
been learned about its size and turnover rates,1 the types of
viruses in it,2 the preferred integration sites,3 and which
stimuli reactivate the latent viruses.4 However, our understanding of how the latent reservoir is formed is still limited
and relies mainly on in vitro infection studies. It is widely
accepted that HIV can only effectively infect activated CD4+
T cells,5–9 and in resting T cells infected in vitro, the virus
enters the cell, but either cannot efficiently complete reverse
transcription8 or cannot integrate its complementary DNA
(cDNA) into the host genome.10,11 The currently favored
model of latent reservoir formation is that HIV cannot directly infect resting CD4+ T cells. Rather, activated CD4+ T
1
2

cells are infected and then revert to a resting phenotype with
integrated provirus to form the latent reservoir.
However, more recent in vivo and ex vivo studies showed
that resting CD4+ T cells were productively infected in vivo,
or can be infected directly ex vivo,12–18 especially in the
context of lymphoid tissues. One of the studies found that
resting CD4+ T cells support HIV replication in lymphoid
tissue (tonsil) explants, whereas purified tonsillar resting
CD4+ T cells did not support HIV replication.19 These studies
suggest that the in vivo lymphoid tissue microenvironment
plays a crucial role in inducing productive and possibly latent
infection in resting CD4+ T cells; therefore, further investigation of the microenvironment and cell-to-cell interactions
within those microenvironments is greatly needed.
Two studies by Choi et al.20,21 demonstrated that stimulation by endothelial cells (ECs) rendered resting memory
CD4+ T cells permissive for productive HIV-1 infection.
This suggested that ECs, which physiologically serve as antigen presenting cells to T cells, particularly in lymphoid
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microenvironments, might play a significant role in infection of
resting CD4+ T cells in vivo.
In our last study, we verified that upon EC stimulation,
resting CD4+ T cells can be productively infected by HIV
while remaining in a resting phenotype. We further demonstrated that EC stimulation can result in latent infection in
resting CD4+ T cells as well, although EC stimulation did not
reactivate already latent HIV provirus from patient T cells.22
We also found that cell death was reduced in infected resting
CD4+ T cells that were stimulated by EC compared to infected activated T cells. When the life span of infected cells is
prolonged, there may be increased viral production and an
increased chance of latency formation. Overall in the last
study, we demonstrated that EC stimulation played a significant role in HIV infection of resting CD4+ T cells and
latent reservoir formation; therefore, characterizing this
stimulation process is important in understanding HIV latency and infection.
It was previously thought that cell-to-cell contact between
resting CD4+ T cells and EC must be present to stimulate the
resting cells and induce productive infection.20,21 The stimulation was thought to be dependent on MHC-II and CD58
found on EC.20,21 However, further investigation by our
laboratory showed that EC did not need to express MHC-II to
induce productive infection22 and CD58 was not sufficient in
stimulation of T cells (unpublished data). These discoveries
led to the present study on the effect of EC-secreted soluble
factors in T cell stimulation.
In addition, various proteins were discovered to either block
or allow HIV infection in resting CD4+ T cells. One of these
proteins is c-Jun N-terminal kinase ( JNK), which is highly
expressed in activated CD4+ T cells, but relatively absent in
resting CD4+ T cells. HIV infection of resting T cells is believed to be blocked at the integration step. Phosphorylated
JNK (p-JNK) phosphorylates and thus activates viral integrase,
which enables completion of viral integration into the host
genome.23 Another protein that is known to affect HIV infection levels in CD4+ T cells is Murr1, a protein commonly
known for its involvement in copper regulation. Murr1 was
previously found to inhibit HIV growth in resting CD4+ T cells,
by inhibiting nuclear factor (NF)-jB activity.24 Finally, increased glucose transporter-1 (Glut1) expression and increased
glucose uptake were found to be associated with increased HIV
infection of CD4+ T cells.25 In this study, we investigate
whether these three intracellular factors are implicated in EC
stimulation of resting CD4+ T cells.
Materials and Methods
Virus production

The procedure for creating the green fluorescence protein
(GFP) reporter virus has been previously described.22 Briefly,
the enhanced green fluorescence protein (eGFP or GFP) reporter virus was generated by cotransfecting HEK293T cells
with a plasmid encoding NL43-dE-GFP and a plasmid encoding the HIV-1 envelope (pWE-CXCR4) using TrueFect
(United BioSystems) at a 2:1 ratio (pNL43:pWE). Supernatants were collected after 72 h and filtered through a 0.22 lm
membrane to remove cell debris. Virus particles were pelleted
using Lenti-X concentrator (Clontech Laboratories) by following the manufacturer’s instructions and resuspended with
1/27 of the original volume of RPMI +10% FBS.
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Isolation of T cells and T cell activation in vitro

Primary T cells were obtained by processing peripheral
blood mononuclear cells (PBMC) from HIV-negative donors
as described.22 Briefly, a Ficoll-Hypaque sugar gradient was
used to extract PBMC, and a magnetic bead-negative depletion
kit was used for isolating CD4+ T cells (Miltenyi Microbeads).
T cell activation through anti-CD3 and anti-CD28 antibodies
(BD Biosciences) was also described previously.22
Direct contact in vitro infection assay

The procedure for the EC in vitro assay has been described
previously.22 Briefly, human umbilical vein endothelial cells
(HUVECs or ECs) were purchased (PromoCell) and cultured
with or without interferon gamma (IFN-c; 50 ng/ml; Invitrogen) for 3 days. IFN-c induces the expression of MHC-II on
EC. EC+ and EC- indicate treatment with or without IFN-c,
respectively. Resting CD4+ T cells were cultured with EC for
1 day before infection with a GFP reporter virus. All cultures
were examined at the peak of their infection, which Shen et al.
have shown to be 6–7 days after infection for resting cultures,
and 3 days after infection for T cells activated with anti-CD3
and anti-CD28 antibodies,22 unless stated otherwise.
Transwell in vitro infection assay

A similar experimental procedure was used as mentioned
in direct contact. ECs treated with or without IFN-c (EC+/-)
were plated with 100% confluency on the bottom of a 24-well
cell culture plate in 0.5 ml of RPMI +10% FBS, and 300 lL of
resting CD4+ T cells in the concentration of 1 million per ml
was added in Corning Transwell Inserts (24-well inserts,
polyester or polycarbonate, pore size of 0.4 lm; SigmaAldrich) that rested over the EC cultures. The cells incubated
together for a day, and then the GFP reporter virus was added.
Infection rates were examined 7 days postinfection by measuring the percent of GFP-positive cells. When transwell
experiments were compared with direct contact setup, 48well plates were used in direct contact wells because they had
similar diameter as the 24-well inserts.
Detection of latent infections

As described previously,22 to detect latent infection, infected T cells were sorted for GFP-negative cells on day 8
postinfection. GFP-negative cells were then cultured alone or
activated with phorbol myristate acetate (PMA) and Ionomycin for 2 days along with the integrase inhibitor raltegravir
to block any integration during activation. GFP expressions
were then compared in cultures with or without activation.
Removal of T cells from EC stimulation

Initial experimental setup is similar to that of the in vitro
infection assays mentioned above. For direct contact removal
experiments, after resting CD4+ T cells (cocultured with EC)
were infected, on day 1 and 3 postinfection, one third of the
resting T cells were removed from the EC coculture and placed
in a separate well. To ensure there were no residual EC in the
removed resting T cells, the T cells were moved to another well
after 4 h settling time (to let EC adhere). No additional media
were added to either the separated wells or the original coculture wells. GFP expressions were measured in the separated
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wells and the original coculture wells on day 6 postinfection.
For the transwell experiments, ECs (+/-) were plated at the
bottom of a 24-well cell culture plate in 200 ll of RPMI +10%
FBS. Corning Transwell Inserts were placed above the EC
cultures, and 100 ll of resting CD4+ T cells was added at a
concentration of 5 million per ml. The cells incubated for a day,
and then 100 ll GFP reporter virus was added. One day after
infection, the virus and soluble factors were washed from the
cell culture inserts by removing the inserts, placing them in an
empty cell culture well, and allowing the media to drain for an
hour. The media surrounding the ECs were also removed, and
1 ml of fresh RPMI +10% FBS was added. The cell culture
inserts were then returned to their original wells (with EC on
the bottom), and 70 ll of resting T cells was removed from the
cell culture inserts on days 1, 3, 5, and 7 postinfection and
placed in a separate well containing 930 ll of fresh RPMI +
10% FBS. On day 7 postinfection, GFP expressions were
measured in the T cells from each of the wells removed at
different times postinfection.
Multiplex cytokine enzyme-linked
immunosorbent assay

Resting CD4+ T cells isolated from HIV-negative donors
were cultured alone, or with EC-, EC+ (EC+ and EC- indicate
treatment with or without IFN-c, respectively), or MCF7
(human adenocarcinoma cell line, ATCC) for 6 days, and the
supernatants were collected and stored at -80C. The supernatants were analyzed using human cytokine magnetic 30plex panel kit (Millipore) at the Human Immunology Core at
the University of Pennsylvania according to the manufacturer’s protocol. Briefly, after washing the 96-well magnetic
plate, 25 ll of each sample, 25 ll of assay buffer, and 25 ll of
beads were added per well. Following an overnight incubation on the shaker at 600 revolutions/min at 4C, the plate was
washed and then incubated with 25 ll of biotinylated detector
antibody for 1 h and then with 25 ll of Streptavidin-RPE for
30 min on the shaker in the dark. After two washes, the assay
plate was transferred to the Bio-Plex Luminex 200 instrument
for analysis. Cytokine concentrations were calculated using
Bio-Plex Manager 5.0 software with a five parameter curvefitting algorithm applied for standard curve calculations. The
levels of the cytokines present in EC+/- cocultured with
resting CD4+ T cells were compared with those present in
resting T cells alone or resting T cells cocultured with MCF7.
T cell stimulation with IL-6, IL-8, and CCL2

Resting T cells were treated with recombinant human IL-6
(1 ng/ml; BioLegend), IL-8 (4 ng/ml; BioLegend), and CCL2
(MCP-1) (50 ng/ml; BioLegend) at concentrations several
folds higher than those in EC cultures determined by the
multiplex enzyme-linked immunosorbent assay (ELISA) to
ensure potency of recombinant cytokines. After incubation
with the cytokines for 1 day, the T cells were infected with the
reporter virus. Cytokine levels were refreshed 1, 3, and 5 days
after infection, and the cells were examined for infection
levels on the sixth day postinfection.

MORRIS ET AL.

CD4+ T cells were added in equal volumes to the EC allowing
for contact, while anti-IL-6 antibodies were refreshed 1 and
3 days postinfection. Infection levels were measured 6 days
after infection.
Intracellular staining of MURR1 and p-JNK

We compared levels of MURR1 and p-JNK expressed in
resting cells, EC-stimulated resting cells, and cells activated
by PMA (Sigma) and Ionomycin (Sigma) or phytohemagglutinin (PHA; Sigma). Approximately 2 · 105 cells were
fixed and permeabilized using 4% formaldehyde and 0.1%
Triton X-100 for MURR1 staining, or a Cytofix/Cytoperm kit
(BD Biosciences) for p-JNK staining. After fixation and
permeabilization, cells were stained in a 3% bovine serum
albumin (BSA) solution by adding either the 2 ll of 1:10
diluted anti-MURR1 Ab (Origene) or 2 ll of the PhosphoSAPK/JNK (Thr183/Tyr185) (G9) Mouse mAb (Cell Signaling Technology). Cells were allowed to incubate at 4C
for 20 min in the dark and then were washed and resuspended
in 100 ll of 3% BSA solution +6 ll of 1:27 diluted anti-IgG1
antibody (BioLegend). Samples were incubated for another
20 min at 4C, in the dark, and were immediately analyzed on
a BD FACSCalibur flow cytometer. To remove additional
background, samples of each culture type were stained with
the anti-IgG1 antibody alone, and that value was subtracted
from experimental values to account for nonspecific binding.
JNK western blot

Approximately 3 · 105 cells were resuspended in a lysis
buffer (62.5 mM Tris-HCl, pH 6.8, 25% glycerol, 2% sodium
dodecyl sulfate, and 0.01 Bromophenol Blue). The cells were
then treated with Dithiothreitol (50 mM), briefly boiled and
loaded on a Novex 12% Tris-Glycine Gel 1.0 mm, 10 well
(Invitrogen). Samples were run at 125 V overnight and then
transferred to a cellulose membrane using the XCell II Blot
Module CE Mark (Invitrogen) in Odyssey Blocking Buffer
(LI-COR Biosciences). JNK FL Antibody (Santa Cruz Biotechnology) was diluted at 1:2,000 and allowed to incubate
with the membrane while shaking for 3 h. The blot was rinsed
in Tris-buffered saline with Tween (TBST), immersed IRDye
800CW Goat Anti-Rabbit IgG (LI-COR Biosciences), and
allowed to incubate while shaking for 1 h. The blot was again
washed in TBST and immediately imaged on the Odyssey
Infrared Imager (LI-COR Biosciences).
GLUT1 antibody staining

Approximately 1 · 105 cells were washed with phosphate
buffered saline, and Mouse Monoclonal (IgG2b) to Human
SLC2A1/GLUT-1 (0.1 lg/ll; LSBio) was added. Cells were
then incubated for 20 min in the dark, rewashed, and incubated with APC/Cy7 goat anti-mouse IgG (20 ng/ll; BioLegend) for another 20 min in the dark. After a final wash, the
cells were analyzed on a BD FACSCalibur flow cytometer
using the CellQuest Pro program (Becton Dickinson).
Results

Blocking IL-6 interactions with T cells

Resting CD4+ T cells can be stimulated by EC
without direct contact

ECs were plated and treated with LEAF Purified antihuman IL-6 antibody (1 mg/ml; BioLegend) for 1 h. Resting

We previously demonstrated that direct contact with EC
can stimulate resting CD4+ T cells for productive HIV
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infection while remaining in the resting phenotype.22 In this
study, we first examined whether resting CD4+ T cells could
be stimulated without direct contact, rather by soluble factors
secreted by EC. Resting CD4+ T cells were isolated from HIVnegative donors and cocultured with EC+ and EC- (previously
treated with or without IFN-c, respectively) in setups that allowed for direct contact or only soluble factor exchange, that
is, in transwells. Treatment of IFN-c for 3 days induced expression of MHC-II on EC. To ensure the size of the wells in
normal and transwell wells does not affect infection rates,
resting CD4+ T cells were cultured alone in normal wells or in
transwells to serve as controls. After 1 day of coculturing, T
cells were infected with the GFP reporter virus, and infection
rates (%GFP+) were examined on day 7 postinfection.
As seen in Figure 1, while resting CD4+ T cells cultured
alone in normal wells or in transwells showed the same
amount of infection, higher infection rates were observed in
resting T cells stimulated by EC (+ and -) in transwells
compared to resting cells alone. When direct contact was
allowed, EC+-stimulated T cells had substantially higher infection rates than those stimulated in transwells, while ECstimulation in direct contact resulted in just slightly more
infection rates than stimulation in transwells.
This suggests that, while soluble factors only accounted for
about half of the effect in EC+ stimulation, they accounted for
the majority of the effect of EC- stimulation. The data also
show that when only soluble factor exchange was permitted,
the infection rates of EC+- and EC--stimulated T cells were
similar, suggesting that similar soluble factors were involved
in both EC+ and EC- stimulations.
Soluble factors secreted by EC can induce latent HIV
infections in resting CD4+ T cells

We have shown previously that stimulation by EC resulted
in latent HIV infection of resting CD4+ T cells,22 so we

FIG. 1. Resting CD4+ T cells can be stimulated by EC
without direct contact. Resting T cells were cultured alone, in
direct contact with EC, or without direct contact, but in
transwells with EC. EC+ and EC- indicate treatment with or
without IFN-c, respectively. Activated T cells (AC) through
CD3 and CD28 stimulations were included as a control. All T
cells were infected with a HIV reporter virus expressing GFP
1 day after coculture, and the %GFP+ cells were measured on
day 7 postinfection. Samples were taken in quadruplicates,
and means – standard errors are plotted. Data shown are the
representative of four independent experiments yielding
similar results. *p < .05, Student t test. EC, endothelial cell;
GFP, green fluorescence protein; IFN-c, interferon gamma.
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decided to test if soluble factors would also allow for latent
infection. Resting T cells were cultured alone, activated with
CD3/CD28, or cultured with EC- or EC+ in transwells for
1 day before infection with a GFP reporter virus. On day 8
postinfection, infected cells were sorted for the GFP-negative
fraction (which contains both uninfected and latently infected
cells). GFP-negative cells were then cultured with or without
PMA and Ionomycin (PMA/I) for 2 days. An integrase inhibitor raltegravir was included to prevent de novo virus integration. Since PMA/I is known to reactivate latent HIV, the
increase of GFP-positive cells in T cells activated by PMA/I
compared to T cells that are not activated by PMA/I is due to
latently infected cells.
As shown in Figure 2, the increase in GFP expression in
PMA/I-activated cultures (induced) compared with unactivated cultures (uninduced) was higher in EC-- and EC+stimulated T cells (in transwells), suggesting that soluble
factors secreted by EC were able to induce latent infection in
resting CD4+ T cells. In addition, the increase of GFP expression was greater in EC-stimulated resting T cells than
that in T cells cultured alone (R). This result suggests that
soluble factors secreted by EC were able to increase latent
infection in resting CD4+ T cells. Finally, as was seen previously,22 no increase in GFP expression was seen in activated T cells upon PMA/I stimulation, indicating there were
no latently infected cells.
Early removal of T cells from EC resulted in reduced
productive and latent infections

One of the questions we were interested in investigating
was how long the resting T cells needed to be stimulated by
EC to achieve maximum infection. To set up the experiments,
resting CD4+ T cells were isolated and cultured with EC(+/-)
in direct contact or in transwell inserts (soluble factors only).
After 1 day, the resting cells were infected with GFP reporter
virus, and then they were removed from EC at various days
postinfection and cultured separately. GFP expressions were
measured on day 6 or 7 postinfection.

FIG. 2. Soluble factors secreted by EC can induce latent
HIV infections in resting CD4+ T cells. Resting CD4+ T cells
were cultured with or without EC in transwells and infected
1 day later with a GFP reporter virus. GFP-negative cells were
sorted on day 8 postinfection and treated with or without PMA/
I to reactivate latent virus (labeled as induced and uninduced,
respectively). GFP was measured 2 days after PMA/I treatment. Samples were taken in duplicates, and means – standard
errors are plotted. Data shown are the representative of three
independent experiments yielding similar results. *Student
t-test; p < .05. #Uninduced resting T cells at 0%. PMA, phorbol
myristate acetate; PMA/I, PMA and Ionomoycin.

Downloaded by CALVIN UNIVERSITY from www.liebertpub.com at 06/04/22. For personal use only.

114

MORRIS ET AL.

We found that infection rates were higher the longer the
resting T cells were allowed to be cocultured with EC, in both
direct contact settings (Fig. 3A) and in transwell settings
(Fig. 3B). The maximal infection rates were achieved at day 5
postinfection, but not earlier. Moreover, while in the direct
contact setting, EC+ stimulation resulted in higher infection
rates at all time points compared with EC- stimulation; in
transwell settings, there was no difference between EC+ and
EC- stimulations at any time point (Fig. 3A, B). This suggests
that similar soluble factors were again involved in both EC+
and EC- stimulations, whereas different cell surface molecules
were involved in direct contact.
Finally, we investigated whether longer or shorter stimulation time between EC and T cells would result in more
latent infection, as latent infection may require more or less
stimulation than productive infection. To set up the experiments, resting CD4+ T cells were isolated and cultured with
EC(+/-) in direct contact for 1 day before infection. On days
1 and 3 postinfection, one third of the T cells were removed
from the coculture and cultured alone until day 8 postinfection. Then, GFP-negative cells were sorted out from each
separate culture, and each cultured with or without PMA/I.
GFP expressions were measured 2 days later.
As shown in Figure 3C, latent infection was observed for
all stimulation times. For EC- stimulated cultures, removal at
day 1 resulted in significantly less latent infection than at day
8, but removal at day 3 was very similar or had even higher
latent infection than removal at day 8. For EC+ cultures, all
time points looked similar to one another. Altogether, these
results suggest that the longer the stimulation between EC
and T cells, the higher the infection rates. For productive infection, it may require up to 5 days of stimulation, whereas for
latent infection, 1–3 days of stimulation seemed sufficient.
ELISA multiplex assay suggests involvement
of IL-6, IL-8, and CCL2

To determine which EC soluble factors were involved in
stimulating the resting CD4+ T cells, we decided to perform a
multiplex ELISA. To prepare for the assay, resting CD4+ T
cells were cultured alone or with EC+ and EC- for 6 days and
the supernatant was collected and frozen at -80C. Supernatants collected from MCF7 cells (also cocultured with
resting CD4+ T cells for 6 days) and resting CD4+ T cells
cultured alone were used as negative controls. MCF7 stimulation does not induce HIV infection of resting CD4+ T
cells.22 Culture supernatants from EC+ and EC- cultured alone
without T cells were also included in the analysis of IL-6.
After analyzing various cytokine data from the multiplex
ELISA, we found that among the 30 cytokines we examined
on the panel, IL-6, IL-8, and CCL2 levels had the most difference between the EC cocultures and the negative controls:
resting CD4+ T cells alone or cocultured with MCF7 (Fig. 4).
Compared to EC cultured alone, addition of T cells resulted
in a slight increase of IL-6 secretion (Fig. 4A).
IL-6 stimulation increases productive infection
in resting CD4+ T cells

After finding three candidate cytokines from the multiplex
ELISA, we investigated the effect of these cytokines, IL-6, IL8, and CCL2, on HIV infection of resting CD4+ T cells.
Resting CD4+ T cells were isolated and incubated with

FIG. 3. Early removal of T cells from EC resulted in
reduced productive and latent infections. (A) Early removal
of resting CD4+ T cells stimulated by direct contact with
EC. Resting T cells were cultured in contact with EC- or
EC+, infected with a GFP reporter virus, and were removed
at various time intervals after infection. The %GFP+ cells
were measured on day 6 postinfection for all cultures, and
the days that the resting CD4+ T cells were removed postinfection are as indicated. Samples were taken in triplicates,
and means – standard errors are plotted. Data shown are the
representative of three independent experiments yielding
similar results. (B) Early removal of resting CD4+ T cells
stimulated by soluble factors with EC. Resting CD4+ T cells
were cultured with EC- or EC+ in transwells, infected 1 day
later with a GFP reporter virus, and removed at the indicated days postinfection. GFP expressions were measured
on day 7 after infection. Samples were taken in quadruplicates, and means – standard errors are plotted. Data
shown are the representative of four independent experiments yielding similar results. (C) Latent infection in early
removal of resting CD4+ T cells from EC stimulation.
Resting CD4+ T cells were cultured in direct contact with
EC, and on various days postinfection, a portion of cells
were removed. On day 8 postinfection, GFP-negative cells
were sorted and cultured with or without PMA/I (labeled as
induced and uninduced, respectively) for 2 days to reactivate latent virus. Samples were taken in triplicates, and
means – standard errors are plotted. Data shown are the
representative of three independent experiments yielding
similar results. *Student t-test; p < .05.
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FIG. 4. Levels of IL-6, IL-8, and CCL2 in cultures of resting CD4+ T cells stimulated by EC. Resting CD4+ T cells were
cultured alone, with MCF7, or with EC+/EC- for 6 days, and the supernatants were collected and analyzed for 30 cytokines.
(A) IL-6 levels in resting T cells cultured alone or stimulated by EC. EC cultured alone were included as well. (B) IL-8
levels in resting T cells cultured alone, with MCF7 or stimulated by EC. (C) CCL2 levels in resting CD4+ T cells cultured
alone, with MCF7 or stimulated by EC. Samples were averaged from two different donors each in duplicates, and
means – standard errors are plotted.
recombinant human IL-6, IL-8, and CCL2 first at concentrations similar to those produced by EC cultures (as shown
measured in Fig. 4) and later at several fold higher concentrations to ensure the potency of recombinant cytokines. After
1 day of incubation with the cytokines, the T cells were infected with a GFP reporter virus. The cells were incubated for
6 days, while the cytokine concentrations were refreshed every
other day postinfection. The %GFP+ cells were measured on
day 6 postinfection in each treatment.
As seen in Figure 5A, only treatment with IL-6 resulted in
increased infection levels in resting CD4+ T cells, while IL-8
and CCL2 had no effect. When we treated resting T cells with
increasing concentrations of IL-6, infection rates in those
cells were dose dependent (Fig. 5B). At the highest concentration of IL-6, the infection rate was very similar to that in
EC--stimulated T cells. When all three cytokines were added
together to resting T cells, no increase of infection rates was
detected beyond IL-6 stimulation alone (data not shown).
To confirm that IL-6 was responsible for increased infection rates in EC-stimulated resting CD4+ T cells, we decided
to block it with an anti-IL-6 antibody. ECs were plated and
treated with an anti-human IL-6 antibody at three different
concentrations of 10, 5, and 2 lg/ml. Then, resting T cells
were added to EC allowing for contact, but not allowing for
IL-6 interaction. After 1 day, T cells stimulated by EC, with
or without anti-IL-6 antibody or with an isotype control antibody, were infected and GFP levels were measured on day 6
postinfection.
As seen in Figure 5C, the addition of anti-IL-6 antibody at
all three titration levels resulted in the same and significantly
lower infection rates in resting cells stimulated by EC- and EC+.
For some of the experiments, we also measured IL-6 levels
using ELISA in IL-6 antibody blocking wells, and the free IL-6
levels in those wells were essentially zero (data not shown).
We also performed IL-6 antibody blocking experiments in
transwell settings at the 10 lg/ml concentration, and the re-

sults showed that EC stimulations were blocked by the antibody (Fig. 5D). In the case of resting cells stimulated by
EC-, the addition of anti-IL-6 antibody reduced the infection
rates to the level of unstimulated resting cells, suggesting that
IL-6 was solely responsible for the effect of EC- stimulation
in transwell. For EC+ stimulation, however, addition of antiIL-6 antibody did not completely reduce the infection level to
that of unstimulated resting cells, suggesting that for EC+
cells, soluble factors other than IL-6 were also involved in
stimulation of resting T cells.
To confirm that IL-6 did not activate resting T cells while
rendering resting T cells permissive for HIV infection, we
measured the expression of activation markers in resting T
cells on the day of infection, and 3 and 6 days postinfection.
While there was significant increase of infection in IL-6stimulated cells on day 6 postinfection (right two bars), at any
time point measured, no significant amount of activation
markers was detected (Fig. 5E).
IL-6, IL-8, or CCL2 treatments of resting CD4+
T cells do not increase latent infection

Once we confirmed that IL-6 induced productive infection
in resting CD4+ T cells, while IL-8 and CCL2 did not, we
decided to investigate whether these cytokines would induce
latent infection in resting CD4+ T cells. Resting T cells were
cultured alone or with IL-6 or CCL2 for 1 day before infection with a GFP reporter virus. On day 8 postinfection, GFPnegative cells were sorted out and cultured alone or treated
with PMA and Ionomycin and the integrase inhibitor raltegravir for 2 days. GFP expressions were compared between
the induced group (treated with PMA/I) and the uninduced
group (untreated) (Fig. 6A). Similarly, in a separate experiment, resting T cells cultured alone were compared with
resting T cells stimulated by EC- in transwells, by IL-6 or IL8 (Fig. 6B).
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FIG. 5. IL-6 stimulation increases productive infection in resting CD4+ T cells without T cell activation. (A) Three different
cytokines, IL-6, IL-8, and CCL2, were added to resting CD4+ T cells 1 day before infection with a virus expressing GFP.
Cytokines were replenished every other day after infection, and GFP-positive rates were measured on day 7 postinfection. (B)
IL-6 concentration is positively associated with infection rates. Resting T cells were cultured with various concentrations of
IL-6 1 day before infection with a reporter virus. The cytokine was replenished on days 1, 3, and 5 postinfection, and GFP was
measured on day 6 postinfection. Resting T cells alone and resting T cells cultured with EC- or EC+ were used as controls. (C)
EC stimulation is blocked by anti-IL-6 antibody. An anti-IL6 antibody (Ab) was added to EC+/- for approximately an hour
before addition of resting T cells in direct contact at three concentrations (10, 5, and 2 lg/ml). After culturing for a day, the
cells were infected with a virus expressing GFP. The antibodies were refreshed on days 1 and 3 postinfection, and GFP levels
were measured on day 6 postinfection. (D) Similar to the experiment in (C), except that T cells were cultured in transwell with
EC. Antibody level was at 10 lg/ml. Resting CD4+ T cells cultured alone or treated with IL-6 served as controls. (E) Lack of T
cell activation by IL-6 stimulation. Resting CD4+ T cells were cocultured with IL-6 at 1 ng/ml for 1 day and then infected with
a GFP reporter virus. CD25, CD69, and HLA-DR levels were measured on the day of infection (D0) and day 3 (D3) and 6
(D6) postinfection. The cytokine was replenished on days 1, 3, and 5 postinfection, and GFP was measured on day 6
postinfection (the right two bars). Samples were taken in triplicates, and means – standard errors are plotted. Data shown are
the representative of at least three independent experiments yielding similar results. *Student t-test; p < .05.
Compared with resting cells alone, neither IL-6 nor CCL2
stimulations induced any additional latent infection, whereas
IL-8 stimulation may have had slightly increased latent infection in comparison to resting cells alone, but it was much
less than latent infection induced by EC- (in transwells).

p-JNK, MURR1, and GLUT1 are not involved
in EC stimulation

To explore what cellular changes occur after the resting T
cells were stimulated by EC, we examined various proteins
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FIG. 6. IL-6, IL-8, and CCL2 treatments do not increase
latent infection. Resting cells were cultured with EC-, untreated, or treated with IL-6, IL-8, CCL2, and infected with
a GFP reporter virus the next day. GFP-negative cells were
sorted out on day 8 postinfection. Sorted cells were either
uninduced or induced with PMA/I for 2 days before GFP
analysis. (A) IL-6 and CCL2 do not induce latent infection
more than resting alone. (B) IL-8 induces slightly more latency than resting alone and IL-6, but much less than EC(through transwell)-stimulated resting cells. Samples were
taken in quadruplicates, and means – standard errors are
plotted. Data shown are the representative of two independent experiments yielding similar results.
that have been shown to affect HIV infection in resting CD4+
T cells,23–25 namely JNK, MURR1, and GLUT1. We compared the expressions of these proteins in stimulated and
unstimulated resting CD4+ T cells.
Expression of JNK, or more precisely p-JNK, was shown
to allow integration of HIV into the host cell genome.23 To
compare p-JNK levels, we performed intracellular staining on
resting T cells cultured alone, cocultured with EC+/-, and activated with PMA/I (which are known to activate p-JNK),
using primary and secondary antibodies. A sample stained
only with the secondary antibodies was included as a nonspecific staining control for each treatment. As seen in Figure 7A,
while activated T cells had significantly higher levels of p-JNK
than resting T cells alone, p-JNK expression was similar
between resting T cells cultured alone and those stimulated
with ECs, indicating that EC stimulation did not increase
p-JNK levels.
To confirm the intracellular staining data, we performed a
western blot on resting T cells cultured alone, cocultured with
EC+/-, and activated with PMA/I using a different antibody,
JNK-FL. Similar results were observed: while activated T
cells showed higher JNK levels, EC-stimulated T cells had
similar levels of JNK as resting T cells alone (Fig. 7B).
Next, we examined whether infected T cells would have
higher levels of p-JNK by comparing p-JNK levels in GFP+
(infected) cells and GFP- (uninfected) cells. Resting T cells
cultured alone or cocultured with ECs were infected for
6 days, and GFP+ and GFP- fractions of the cells were sorted
out and p-JNK levels were measured through intracellular
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staining. As shown in Figure 7C, there was no difference
in p-JNK levels between GFP+ and GFP- cells in any
treatment group.
MURR1 was found to block HIV replication in resting T
cells,24 so we expected to find a decrease of Murr1 in ECstimulated cells and low levels of MURR1 in infected cells.
Therefore, we infected resting T cells cultured alone, cocultured with EC, and activated with PHA, which were sorted
for GFP-positive and GFP-negative fractions 6 days postinfection, and then MURR1 levels were measured in each
fraction. We found no decrease of Murr1 expression in ECstimulated resting CD4+ T cells compared with resting T cells
cultured alone (Fig. 7D). MURR1 levels were actually higher
in GFP+ (infected) cells than GFP- (uninfected) cells,
showing that Murr1 expression did not hinder HIV infection.
Glut1 expression was found to correlate with HIV infection,25 so we infected resting T cells cultured alone, cocultured
with EC, and activated with PHA, and then measured GLUT1
levels. As seen in Figure 7E, while activated T cells had significantly higher levels of GLUT1 than resting T cells alone,
Glut1 expression was similar between resting T cells cultured
alone and cocultured with ECs, indicating that EC stimulation
did not significantly increase GLUT1 levels. Furthermore, the
percentage of GFP-positive cells was much higher than the
percentage of GLUT1-positive cells in either resting T cells
cultured alone or EC-stimulated resting T cells, indicating that
Glut1 expression did not correlate with HIV infection in
resting T cells or resting T cells stimulated by EC.
Discussion

In this study, we determined that direct cell-to-cell contact
between EC and resting CD4+ T cells was not necessary to
stimulate resting T cells, and a substantial amount of productive infection was achieved in transwell settings, which
only allow for exchange of soluble factors between ECs and
resting T cells (Fig. 1). However, infection rates were significantly higher in direct contact settings than in transwell
settings; therefore, it is likely that both soluble factors and
cell surface molecules played a role. This is further supported
by the experiment illustrated in Figure 5C, where blockage of
soluble factor IL-6 in resting cells stimulated by EC+ still
resulted in significantly higher infection rates than those in
resting T cells alone.
We also found that soluble factors from EC can induce
higher levels of latent infection than those in resting T cells
cultured alone (Fig. 2). These results suggest that in in vivo
situations, resting T cells do not have to have physical contact
with EC; rather, through soluble factors EC can render resting
T cells permissive for productive and latent infection by HIV.
If physical contact is indeed not required, larger numbers of
resting T cells could be made infectible by EC than previously estimated.
We previously discovered that maximum levels of productive infection in EC-stimulated resting T cells were
achieved at approximately 6–7 days postinfection.22 In this
study, we set out to determine how long it took EC to completely stimulate resting CD4+ T cells to achieve the maximum
amount of productive infection. We found that it was necessary to keep the resting cells exposed to EC until *5 days
postinfection (Fig. 3) to achieve the maximum amount of
productive infection. For latent infection, it seemed to take at
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FIG. 7. JNK, Murr1, and Glut1 expression in resting T cells does not change after stimulation by EC. (A) Resting T cells
were cultured alone, with EC+/-, or with PMA and Ionomycin. p-JNK intracellular staining was done 4 days later for PMA/Iactivated cells, and 7 days later for resting T cells cultured alone or with EC- and EC+. Samples were taken in duplicates, and
means – standard deviations are plotted. Data shown are the representative of two independent experiments yielding similar
results. (B) In a similar way, resting CD4+ T cells were cultured alone, activated with PMA/I, or cocultured with EC- or EC+
and analyzed for JNK expression through western blot analysis. (C) Resting CD4+ T cells were cultured alone or with EC- or
EC+ and infected with a GFP reporter virus the next day. Intracellular staining was done on day 7 postinfection to measure pJNK expression. GFP+ cells were productively infected, and GFP- cells were not productively infected. Samples were taken in
duplicates, and means – standard deviations are plotted. (D) Resting T cells cultured alone or with EC+/- or activated with
PMA/I. Murr1 expression was determined by intracellular staining 7 days after infection. Samples were taken in duplicates,
and means – standard deviations are plotted. Data shown are the representative of two independent experiments yielding
similar results. (E) Resting CD4+ T cells were cultured alone, activated by PHA, or stimulated by EC+/-. Cells were infected
with a GFP reporter virus. GFP expression and GLUT1 staining were performed 3 days after infection for PHA-activated cells
and 7 days after infection for resting cells that were unstimulated or stimulated by EC. Samples were taken in triplicates, and
means – standard errors are plotted. Data shown are the representative of three independent experiments yielding similar
results. *Student t-test; p < .05. Glut1, glucose transporter 1; JNK, c-Jun N-terminal kinase; PHA, phytohemagglutinin; p-JNK,
phosphorylated JNK.
least 3 days. These results showed that the longer the contact
with T cells, either through direct contact or through soluble
factors, the more effect EC has on T cells. Since the maximum
effect takes a few days to achieve, there is a wider window for
therapeutic intervention.
Next, we investigated which soluble factor or factors were
responsible for EC stimulation of resting T cells. We found a
few candidate cytokines and chemokines that were at higher
levels in EC-stimulated resting T cell cultures, and among
them we found IL-6 to be the culprit. IL-6 can definitively
induce higher levels of productive infection in resting T cells,
almost to the level of EC- stimulation in transwells (Fig. 5D).

When IL-6 is blocked by an antibody, the effect of ECstimulation was reduced in direct contact and almost obliterated in transwells (Fig. 5C, D). These results showed that
IL-6 was secreted by EC to render resting T cells permissive
for productive HIV infection. Moreover, just as ECs did not
activate resting T cells,22 with the level we tested in vitro,
resting T cells were not activated by IL-6 stimulation
(Fig. 5E).
IL-6 is a proinflammatory cytokine commonly found
in elevated levels in HIV patients.26–28 In addition, ECs
are not the only cells secreting IL-6 in vivo; many cell
types, including fibroblasts, monocytes/macrophages, and even
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T cells, produce them when stimulated.29,30 The discovery
that IL-6 renders resting T cells permissive for HIV infection
could explain why so many resting T cells are infected in HIV
patients in vivo.31
IL-6 was found to induce productive HIV infection of
resting CD4+ T cells, but not latent infection (Fig. 6). The
other two soluble factors that were at higher levels in stimulated T cell cultures, IL-8 and CCL2, were also not responsible for inducing latent infection.
Many cytokines have been previously identified to be involved in inducing latent HIV infection, including CCL19,
CCL21, IL-7, and IL-15.32,33 In our last study, we investigated their potential involvement in EC stimulation of resting
T cells and found none of them was involved.22 In this study,
more specifically in the multiplex ELISA experiment, we
eliminated many cytokines on the multiplex panel, but we
have not yet found the cytokine or cytokines that were secreted by EC to induce latent HIV infection in resting T cells.
Our plan for the next study is to do an RNA-seq experiment to
investigate which cytokines or chemokines are differentially
expressed in EC compared with those in resting T cells or in
MCF7. Once we identify candidate genes, we will perform
the latency assay to investigate their involvement.
In the last part of this study, we turned our attention to the
changes that would take place within resting T cells after EC
stimulation. To investigate which intracellular molecules might
be allowing productive HIV infection in EC-stimulated resting
CD4+ T cells, we examined three different proteins that were
known to have an effect on HIV infection in resting T cells.
Murr1 was previously thought to inhibit HIV-1 infection,23
but we found this was not the case. Cells infected by the virus
(GFP+) showed higher expression of Murr1 than those that
were not infected by the virus (GFP-), which shows that
MURR1 cannot inhibit HIV-1 infection in T cells (Fig. 7D).
Furthermore, we found that the resting T cells stimulated by
EC had similar levels of MURR1 to the resting cells that were
not stimulated by ECs, meaning that Murr1 expression did
not change after T cell stimulation by EC (Fig. 7D). Actually,
we found activated CD4+ T cells had similar or slightly
higher levels of MURR1 than resting T cells (data not
shown). Therefore, MURR1 did not seem to be involved in
restricting HIV infection of resting T cells.
Two other proteins we investigated were p-JNK and
GLUT1, which were thought to positively affect HIV infection in CD4+ T cells. Loisel-Meyer et al. showed that increased levels of GLUT1 allowed for more productive
infection of HIV. We found this to be true with our activated
and resting CD4+ T cells, but it was not significant in the
resting T cells stimulated by EC, since their expression of
Glut1 was similar to resting populations (Fig. 7E).
Manganaro et al. showed that high JNK expression allows
for productive HIV-1 infection, and we confirmed this by
measuring p-JNK and JNK levels in our activated and resting
CD4+ T cell populations (Fig. 7A–C). The resting T cells
stimulated by EC had similar levels of p-JNK to the resting
CD4+ T cells; therefore, p-JNK was not a factor in allowing
higher HIV-1 infection rates in EC-stimulated resting cells.
Since all of the proteins previously explored do not allow
for productive HIV-1 infection in resting CD4+ T cells
stimulated by EC, more extensive investigations need to be
done. Messenger RNA (mRNA) sequencing can be used to
compare resting T cells before and after stimulation by EC,
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allowing us to see which genes are differentially expressed
after EC stimulation. Discovering the factor(s) that are responsible for HIV infection of resting T cells intracellularly is
important because it will allow us to block them, thus preventing infection of resting CD4+ T cells in vivo and the
formation of latent viral reservoirs. Our plan for the next
study is to do RNA-seq experiment to compare gene expressions in resting T cells cultured alone and those in ECstimulated resting T cells.
Overall, we demonstrated that soluble factors secreted by
ECs can induce productive and latent HIV infections in
resting CD4+ T cells, although infection rates were higher
with physical contact from EC. We further characterized the
interactions between EC and T cells with regard to the length
of contact, cytokines involved, and intracellular factors. We
found that IL-6 secreted by EC is responsible for inducing
productive infection in resting T cells, but not for latent infection. From our previous work22 and the multiplex cytokine
ELISA we did in this study, we found that many cytokines
known to be involved in inducing latent infection in resting T
cells, such as CCL19, CCL21, IL-7, or IL-15, were not involved in EC stimulation of resting T cells.
These results suggest that new and unidentified soluble
factors are involved, and further work is needed to identify
them. In addition, intracellular factors previously identified
to be involved in allowing HIV infection of resting T cells
were not involved in EC stimulation, which suggests yet
another new mechanism exists that allows HIV infection of
resting T cells.
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